Verve Therapeutics Inc. Made Big Gain

Tue, Jul 19, 2022 at 07:09 PM
Verve Therapeutics Inc. Made Big Gain

Verve Therapeutics Inc. (VERV:NASDAQ) shot up at $32.29, representing a gain of 22.7%. On Tue, Jul 19, 2022, VERV:NASDAQ touched a New 2-Week High of $32.29. The stock got featured on our News Catalysts scanner on Tue, Jul 12, 2022 at 06:40 AM in the 'INVESTOR UPDATE' category. From Tue, Jul 05, 2022, the stock recorded 70.00% Up Days and 72.73% Green Days

About Verve Therapeutics Inc. (VERV:NASDAQ)

Verve Therapeutics Inc is a genetic medicines company pioneering the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.